PubMed · 2026561
Novel avermectins produced by mutational biosynthesis.
Abstract
Avermectins with a wide range of novel C-25 substituents have been prepared by feeding carboxylic acids or their biosynthetic precursors to a Streptomyces avermitilis mutant strain ATCC 53568. This organism lacks the ability to form isobutyric and S-2-methylbutyric acids from their 2-oxo acid precursors and thus is unable to produce natural avermectins unless supplied with these acids. The novel avermectins produced by mutational biosynthesis possess broad-spectrum antiparasitic activity.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
C J Dutton, S P Gibson, A C Goudie, K S Holdom, M S Pacey, J C Ruddock, J D Bu'Lock, M K Richards. 1991. Novel avermectins produced by mutational biosynthesis.. https://doi.org/10.7164/antibiotics.44.357
Cite the original work for its findings. Save a collection to share your selection of sources.